ISSN: 2332-0877

Journal of Infectious Diseases & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Infect Dis Ther,
  • DOI: 10.4172/2332-0877.1000525

Long-COVID: A New Name for a Long-Known Symptom Constellation

Gorczynski Reginald Mieczyslaw1*, Edward John Steele2, Wickramasinghe N Chandra3 and Lindley RA4
1Department of Immunology and Surgery, University of Toronto, Ontario, Canada
2Department of Analysis, Melville Analytics Pty Ltd., Melbourne, Australia
3Department of Astrobiology, National Institute of Fundamental Studies, Kandy, Sri Lanka
4Department of Clinical Pathology, University of Melbourne, Melbourne, Australia
*Corresponding Author : Dr. Gorczynski Reginald Mieczyslaw, Department of Immunology and Surgery, University of Toronto, Ontario, Canada, Email: reg.gorczynskI@utoronto.ca

Received Date: Dec 23, 2022 / Published Date: Jan 20, 2023

Abstract

There has been intense interest in the past 18-24 months on the evolution of a symptom complex in individuals previously infected and/or vaccinated with SARS-CoV-2, which has been described to represent a novel entity, named long-COVID. Included in the symptoms are chronic fatigue, myalgias, depression/anhedonia, poor sleep and in some cases evidence for autoimmune-like responses. The potential drain on medical resources for effective treatment of this condition is enormous, and there is some urgency in developing an improved understanding of the pathophysiology behind it. In the review below we argue that this is unlikely in fact to represent a new entity, but a well-described entity of long-standing (myalgic encephalomyelitis/chronic fatigue syndrome, and fibromyalgia). Even simply pooling the limited data on our understanding of the etiology and treatment of these disorders is likely to improve substantially our ability to deal with the number of individuals presenting with long-COVID, and thus lessen some of the adverse psychological effects associated with “labeling” of this condition.

Keywords: SARS-CoV-2; Long-COVID; Fibromylagia; Vaccination

Citation: Mieczyslaw GR, Steele EJ, Chandra WN, Lindley RA (2023) Long-COVID: A New Name for a Long-Known Symptom Constellation. J Infect Dis Ther 11:525. Doi: 10.4172/2332-0877.1000525

Copyright: © 2023 Mieczyslaw GR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top